Breaux P J
J La State Med Soc. 1998 Jun;150(6):275-8.
A new federal law contains specific edicts as to the ability of pharmacists as well as physicians to engage in "anticipatory compounding" of prescription drug orders. It also establishes under what circumstances a pharmacists or physician may compound or mix a prescription drug that is a "near copy" of one already commercially available. This article discusses some of the principal features of that law, which will affect both the prescriber and the compounder and which becomes effective on November 22, 1998.
一项新的联邦法律包含了关于药剂师以及医生进行处方药订单“预期配药”能力的具体法令。它还规定了在何种情况下药剂师或医生可以配制或混合一种与已上市药品“近似仿制品”的处方药。本文讨论了该法律的一些主要特征，这些特征将对开处方者和配药者都产生影响，并且该法律于1998年11月22日生效。
